Venus Concept Inc. (VERO)
| Market Cap | 94.62M |
| Revenue (ttm) | 78.01M |
| Net Income (ttm) | -88.83M |
| Shares Out | 54.07M |
| EPS (ttm) | -2.33 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 13 |
| Last Price | $1.80 |
| Previous Close | $1.79 |
| Change ($) | 0.01 |
| Change (%) | 0.56% |
| Day's Open | 1.78 |
| Day's Range | 1.71 - 1.83 |
| Day's Volume | 263,547 |
| 52-Week Range | 1.60 - 5.00 |
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept (VERO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal yea...
Venus Concept (VERO) delivered earnings and revenue surprises of -37.50% and 0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Venus Concept (NASDAQ:VERO) increased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 74.77% over the past year to ($0.27), which misse...
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will atten...
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...
TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal ye...
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenu...
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...
TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of its public o...
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends to offer an...
New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future cash flow N...
TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company will host ...
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript
Venus Concept (VERO) delivered earnings and revenue surprises of 25.00% and -21.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Venus Concept (NASDAQ:VERO) moved higher by 3.9% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 82.35% over the past year to ($0.18), wh...
TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three a...
TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...
TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year...
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript
Venus Concept (VERO) delivered earnings and revenue surprises of -8.33% and 2.70%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary revenue result...
Venus Viva MD is a new skin rejuvenation solution with differentiated features that allow clinicians in the traditional medical aesthetics community to treat a wider range of skin conditions Venus Viva ...
TORONTO, June 26, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company has been...
Forget undervalued stocks, play these top-ranked stocks with rising P/E.
TORONTO, June 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into ...
Venus Epileve is a new, cost-effective, laser hair removal solution designed for customers in the aesthetics market Venus Epileve is a new, cost-effective, laser hair removal solution designed for custo...
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript
Venus Concept (VERO) delivered earnings and revenue surprises of -14.12% and -13.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
TORONTO, May 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q4 2019 Results - Earnings Call Transcript
TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a d...
Chad A. Zaring, Appointed Chief Commercial Officer Chad A. Zaring, Appointed Chief Commercial Officer
TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE M...
TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary unaudited rev...
About VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and trea... [Read more...]
| Industry Medical Devices | |
| CEO Domenic Serafino | Employees 384 |
| Stock Exchange NASDAQ | Ticker Symbol VERO |
Financial Performance
In 2020, Venus Concept's revenue was $78.01 million, a decrease of -29.34% compared to the previous year's $110.41 million. Losses were -$85.27 million, 109.9% more than in 2019.
Analyst Forecasts
According to 5 analysts, the average rating for Venus Concept stock is "Buy." The 12-month stock price forecast is 5.50, which is an increase of 205.56% from the latest price.